Implications for nutrition practice in the mineral-bone disorder of chronic kidney disease

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Chronic kidney disease (CKD) is estimated to affect ∼13% of the U.S. adult population and will require most healthcare professionals to be aware of management techniques. From stage 1 CKD, where kidney damage may be the only indicator, to stage 5 CKD, where dialysis or a transplant is required, the treatments vary greatly. One of the first systems to be affected by CKD is 1-α hydroxylation of vitamin D by production of the enzyme in the kidney. Alterations in this system contribute to bone disorders that are manifested by mineral changes throughout the course of CKD. This report provides insight on the dietary components and contributions to mineral and bone disorder of CKD and recommendations for treatment when CKD treatment does not require dialysis or transplantation.

Original languageEnglish (US)
Pages (from-to)391-400
Number of pages10
JournalNutrition in Clinical Practice
Issue number4
StatePublished - Aug 2011


  • calcium
  • chronic kidney disease
  • magnesium
  • mineral bone disorder
  • phosphorus
  • potassium
  • renal disease
  • sodium
  • vitamin D

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics


Dive into the research topics of 'Implications for nutrition practice in the mineral-bone disorder of chronic kidney disease'. Together they form a unique fingerprint.

Cite this